COVID-19 hemodynamic and thrombotic effect on the eye microcirculation after hospitalization: A quantitative

Aristotle G Koutsiaris1, Konstantina Riri2, Stylianos Boutlas3

  • 1Medical Informatics Laboratory, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, Larissa, Greece.

Insights

COVID-19 survivors show significantly reduced eye blood flow and increased microthrombosis, even with preventative treatment. This may explain long COVID symptoms and suggest new coagulation factors.

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Infectious Diseases

Background:

  • COVID-19 can affect microcirculation, leading to potential long-term complications.
  • Understanding these effects is crucial for managing post-hospitalization recovery.

Purpose of the Study:

  • To quantify the hemodynamic and thrombotic impact of COVID-19 on ocular microcirculation.
  • To assess these effects in patients receiving thromboprophylaxis after hospital discharge.

Main Methods:

  • A case-control study comparing 17 COVID-19 survivors with 17 healthy controls.
  • Conjunctival Video Capillaroscopy (CVC) used to measure axial blood velocity (Vax) and percentage of occluded vessels (POV).
  • Microvessels analyzed included capillaries (CAP), postcapillary venules size 1 (PC1), and size 2 (PC2).

Main Results:

  • COVID-19 survivors exhibited significantly reduced Vax (39-47%) across all analyzed microvessel types compared to controls.
  • A substantial increase in POV (600%) was observed in COVID-19 survivors.
  • Demographics between the COVID-19 and control groups were comparable.

Conclusions:

  • COVID-19 significantly impairs ocular microvascular blood flow and promotes microthrombosis, even with thromboprophylaxis.
  • These findings offer a potential explanation for persistent symptoms in long COVID.
  • The results suggest the possible involvement of an unidentified coagulation factor in COVID-19's vascular effects.
Abstract

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
711
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
535
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
638